Penumbra (PEN)
(Delayed Data from NYSE)
$189.87 USD
-0.94 (-0.49%)
Updated Jul 19, 2024 04:00 PM ET
After-Market: $189.94 +0.07 (0.04%) 7:58 PM ET
2-Buy of 5 2
C Value A Growth C Momentum B VGM
Price, Consensus and EPS Surprise
PEN 189.87 -0.94(-0.49%)
Will PEN be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for PEN based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for PEN
Here's Why Penumbra (PEN) is a Strong Growth Stock
Here's Why Penumbra (PEN) is a Strong Growth Stock
PEN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Hologic's (HOLX) Surgical Business Set to Propel Q3 Earnings
Will Patient Volumes Drive Universal Health's (UHS) Q2 Earnings?
Penumbra (PEN) Soars 3.3%: Is Further Upside Left in the Stock?
Other News for PEN
UK earnings, trading statements calendar - next 7 days
Med-tech and healthcare stocks with upside during 2Q earnings - Baird
Inari Medical just downgraded at Needham, here's why
Peninsula Energy Expands Shares Quotation
Needham cuts Inari to hold, cites competitive concerns